| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962788 | Vaccine | 2016 | 7 Pages |
Abstract
- FNIII 11-EDA and CpG synergize in vitro to enhance activation of dendritic cells.
- Immunization with both adjuvants induces a potent antigen-specific Th1 response in vivo.
- Co-adjuvanted OVA mediates regression of E.G7-OVA tumors through CTL response.
- Co-adjuvanted HBsAg induces seroconversion and clearance of circulating virus in HBV-Tg mice.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ziad Julier, Alexandre de Titta, Alizée J. Grimm, Eleonora Simeoni, Melody A. Swartz, Jeffrey A. Hubbell,